Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$35.66 - $44.99 $9.86 Million - $12.4 Million
-276,378 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$36.57 - $47.97 $491,281 - $644,428
-13,434 Reduced 4.64%
276,378 $12 Million
Q1 2019

May 07, 2019

BUY
$36.47 - $42.17 $2.09 Million - $2.42 Million
57,318 Added 24.65%
289,812 $11 Million
Q1 2019

May 06, 2019

BUY
$36.47 - $42.17 $282,824 - $327,028
7,755 Added 3.45%
232,494 $11.1 Million
Q4 2018

Feb 19, 2019

SELL
$41.31 - $52.16 $1.67 Million - $2.11 Million
-40,516 Reduced 15.27%
224,739 $12.3 Million
Q3 2018

Nov 19, 2018

SELL
$32.85 - $52.0 $82,946 - $131,300
-2,525 Reduced 0.94%
265,255 $16.4 Million
Q3 2018

Nov 14, 2018

SELL
$32.85 - $52.0 $2.42 Million - $3.84 Million
-73,800 Reduced 21.61%
267,780 $16.2 Million
Q2 2018

Jul 25, 2018

SELL
$27.5 - $39.8 $1.4 Million - $2.03 Million
-50,935 Reduced 12.98%
341,580 $11 Million
Q1 2018

May 11, 2018

BUY
$29.98 - $46.35 $1.75 Million - $2.7 Million
58,218 Added 17.42%
392,515 $12.3 Million
Q4 2017

Feb 09, 2018

BUY
$31.85 - $46.95 $1.89 Million - $2.79 Million
59,455 Added 21.63%
334,297 $15.4 Million
Q3 2017

Nov 14, 2017

BUY
$35.7 - $39.5 $9.81 Million - $10.9 Million
274,842
274,842 $10.4 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Penn Capital Management Company, LLC Portfolio

Follow Penn Capital Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Capital Management Company, LLC with notifications on news.